Published in Cell Adh Migr on January 28, 2007
Pregnancy-associated progenitor cells: an under-recognized potential source of stem cells in maternal lung. Placenta (2011) 0.86
Stem cell therapy: social recognition recovery in a FASD model. Transl Psychiatry (2012) 0.80
Stem cell therapy: a new approach to the treatment of refractory depression. J Neural Transm (Vienna) (2014) 0.76
Gender-linked stem cell alterations in stroke and postpartum depression. CNS Neurosci Ther (2014) 0.75
Fetal microchimeric cells in autoimmune thyroid diseases: harmful, beneficial or innocent for the thyroid gland? Chimerism (2013) 0.75
Existence of Microchimerism in Pregnant Women Carrying a Boy! J Reprod Infertil (2016) 0.75
Differential mouse-strain specific expression of Junctional Adhesion Molecule (JAM)-B in placental structures. Cell Adh Migr (2016) 0.75
The impact of chimerism in DNA-based forensic sex determination analysis. Malays J Med Sci (2013) 0.75
Hypothesis about Transdifferentiation As Backbone of Malignancy. Front Oncol (2017) 0.75
The placental gateway of maternal transgenerational epigenetic inheritance. J Genet (2017) 0.75
Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns. Vaccines (Basel) (2017) 0.75
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Placental development: lessons from mouse mutants. Nat Rev Genet (2001) 6.03
PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med (1993) 4.81
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A (1996) 4.70
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood (2001) 4.22
The placenta is a niche for hematopoietic stem cells. Dev Cell (2005) 3.83
Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 3.43
CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13
The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell (2005) 2.91
Comparative developmental anatomy of the murine and human definitive placentae. Placenta (2002) 2.89
Transfer of fetal cells with multilineage potential to maternal tissue. JAMA (2004) 2.72
Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol (2000) 2.72
Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol (2002) 2.63
Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet (2004) 2.56
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1979) 2.45
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
Animal models of human placentation--a review. Placenta (2006) 2.28
Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A (1990) 2.15
Current topic: in vivo investigation of the placental circulations by Doppler echography. Placenta (1995) 2.13
The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum (2003) 2.03
The biology of PECAM-1. J Clin Invest (1997) 2.01
Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet (1969) 1.97
Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm (Vienna) (2006) 1.96
Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA (2004) 1.95
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A (2007) 1.92
Trophoblast in the circulating blood during pregnancy. Am J Obstet Gynecol (1959) 1.85
Transplacental passage of blood cells. J Med Genet (1975) 1.80
The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol (1967) 1.79
Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol (1999) 1.70
Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood (1999) 1.63
Mouse placenta is a major hematopoietic organ. Development (2003) 1.54
Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med (2005) 1.51
Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion (2001) 1.46
Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2. Cell Microbiol (2005) 1.42
The unfolding tale of PECAM-1. FEBS Lett (2003) 1.41
Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc (1977) 1.39
Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol (2005) 1.37
Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol (1987) 1.35
Blood group chimerism in human multiple births is not rare. Am J Med Genet (1996) 1.28
Microchimerism in pregnant mice. Transplant Proc (1981) 1.27
Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci U S A (2007) 1.27
Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci (2005) 1.26
Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells (2005) 1.22
Cervical cancer and microchimerism. Obstet Gynecol (2003) 1.21
ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. Am J Pathol (1997) 1.16
Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet (2001) 1.13
Bi-directional cell trafficking between mother and fetus in mouse placenta. Placenta (2006) 1.13
Detection and isolation of fetal cells from maternal blood using the flourescence-activated cell sorter (FACS). Prenat Diagn (1981) 1.12
Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol (2002) 1.12
The vanishing twin: a review. Hum Reprod Update (1998) 1.11
Georg Schmorl on trophoblasts in the maternal circulation. Placenta (2006) 1.08
Development of trophoblast and placenta of the mouse. A reinvestigation with regard to the in vitro culture of mouse trophoblast and placenta. Acta Anat (Basel) (1977) 1.08
Maternal cell microchimerism in newborn tissues. J Pediatr (2003) 1.08
Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet (2000) 1.07
The time of appearance and disappearance of fetal DNA from the maternal circulation. Prenat Diagn (1995) 1.07
Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07
Fetal cells in maternal blood: determination of purity and yield by quantitative polymerase chain reaction. Am J Obstet Gynecol (1994) 1.06
Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion. Hepatology (2002) 1.04
Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod (2003) 1.04
Microchimerism and human autoimmune diseases. Lupus (2002) 1.04
Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis (2004) 1.02
Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev (2006) 1.01
The immunology of successful pregnancy. Hum Reprod Update (2003) 1.01
Origin of extraembryonic mesoderm in experimental animals: relevance to chorionic mosaicism in humans. Am J Med Genet (1993) 1.00
Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology (2005) 0.99
Significance of placental pathology in transplacental haemorrhage. J Clin Pathol (1968) 0.99
Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol (2007) 0.98
[The concentration of fetal cells in maternal haematopoietic organs during pregnancy. An experimental study in mice (author's transl)]. J Gynecol Obstet Biol Reprod (Paris) (1978) 0.98
Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis (2003) 0.97
Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet (1990) 0.96
Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol (1991) 0.95
Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med (2002) 0.95
Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update (2004) 0.95
Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood (1998) 0.94
Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis (2003) 0.94
Trophoblast interactions with endothelial cells are increased by interleukin-1beta and tumour necrosis factor alpha and involve vascular cell adhesion molecule-1 and alpha4beta1. Exp Cell Res (2004) 0.93
Microchimerism in human health and disease. Autoimmunity (2003) 0.93
Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta (2004) 0.91
Detection of fetal HPCs in maternal circulation after delivery. Transfusion (2001) 0.89
Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract Res Clin Obstet Gynaecol (2004) 0.89
Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts. J Soc Gynecol Investig (2005) 0.88
A morphologic study of trophoblast isolated from peripheral blood of pregnant women. Am J Obstet Gynecol (1994) 0.88
Phenotype of the endothelium in the human term placenta. Placenta (2001) 0.86
Confined blood chimerism in monochorionic dizygous (MCDZ) twins. Prenat Diagn (2007) 0.86
Evidence for blood chimerism in dizygotic spontaneous twin pregnancy discordant for Down syndrome. Prenat Diagn (2006) 0.83
Fetal cells and DNA in maternal blood. Prenat Diagn (2003) 0.82
Evolution of mammalian pregnancy in the presence of the maternal immune system. Rev Reprod (2000) 0.82
Chimerism in systemic lupus erythematosus--three hypotheses. Rheumatology (Oxford) (2006) 0.82
First trimester prenatal diagnosis: fetal cells in the maternal circulation. Semin Perinatol (1999) 0.81
Nature of stem cell involved in fetomaternal microchimerism. Lancet (2004) 0.81
Expression and secretion of the vascular cell adhesion molecule-1 in human placenta and its decrease in fetal growth restriction. J Soc Gynecol Investig (2003) 0.81
Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol (2000) 0.79
Detection of paternally inherited mutations for beta-thalassemia in trophoblast isolated from peripheral maternal blood. Ann N Y Acad Sci (1994) 0.79
Clinical experience: isolating trophoblasts from maternal blood. Ann N Y Acad Sci (1994) 0.77
Histological examination of first trimester spontaneous abortions: the impact of materno-embryonic interface features. Histopathology (1992) 0.77
Fetomaternal blood group incompatibility studies in placental intervillous thrombosis. Placenta (1983) 0.76
Demonstration of foetal cells in maternal blood. J Med Lab Technol (1969) 0.76
A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat Cell Biol (2008) 2.34
F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell (2003) 2.05
Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem (2002) 1.24
NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol Chem (2004) 1.22
Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells (2005) 1.22
Neural recognition molecules CHL1 and NB-3 regulate apical dendrite orientation in the neocortex via PTP alpha. EMBO J (2007) 1.12
Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination. J Biol Chem (2009) 0.99
Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control. Stem Cells (2009) 0.97
Notch as a molecular switch in neural stem cells. IUBMB Life (2010) 0.96
Cross-talk between F3/contactin and Notch at axoglial interface: a role in oligodendrocyte development. Dev Neurosci (2006) 0.92
Morphological and functional characterization of predifferentiation of myelinating glia-like cells from human bone marrow stromal cells through activation of F3/Notch signaling in mouse retina. Stem Cells (2007) 0.91
Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration. J Neurochem (2004) 0.90
Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biol (2006) 0.90
Effect of fibrin glue on the biomechanical properties of human Descemet's membrane. PLoS One (2012) 0.89
Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of K(+) channel localization. EMBO J (2003) 0.88
Impaired long-term potentiation in c-Jun N-terminal kinase 2-deficient mice. J Neurochem (2005) 0.87
Cell surface sialylation and fucosylation are regulated by the cell recognition molecule L1 via PLCgamma and cooperate to modulate embryonic stem cell survival and proliferation. FEBS Lett (2009) 0.86
Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem (2004) 0.83
Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway. Cell Adh Migr (2012) 0.83
Deletion of TRIM32 protects mice from anxiety- and depression-like behaviors under mild stress. Eur J Neurosci (2014) 0.82
Amyloid precursor protein at node of Ranvier modulates nodal formation. Cell Adh Migr (2014) 0.82
Loss of NB-3 aggravates cerebral ischemia by impairing neuron survival and neurite growth. Stroke (2011) 0.82
A TAG on to the neurogenic functions of APP. Cell Adh Migr (2008) 0.82
CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol Cell Neurosci (2010) 0.81
Cobalt chromium alloy with immobilized BMP peptide for enhanced bone growth. J Orthop Res (2011) 0.81
AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stress. J Biol Chem (2014) 0.80
Caspr4 interaction with LNX2 modulates the proliferation and neuronal differentiation of mouse neural progenitor cells. Stem Cells Dev (2014) 0.80
Receptor-like protein-tyrosine phosphatase α enhances cell surface expression of neural adhesion molecule NB-3. J Biol Chem (2011) 0.80
Mature BDNF promotes the growth of glioma cells in vitro. Oncol Rep (2013) 0.80
Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. J Biol Chem (2004) 0.79
Crystal structure of the N-terminal methyltransferase-like domain of anamorsin. Proteins (2013) 0.78
Potential role of 20S proteasome in maintaining stem cell integrity of human bone marrow stromal cells in prolonged culture expansion. Biochem Biophys Res Commun (2012) 0.78
Physiological roles of neurite outgrowth inhibitors in myelinated axons of the central nervous system--implications for the therapeutic neutralization of neurite outgrowth inhibitors. Curr Pharm Des (2007) 0.78
Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson's disease. Gene (2013) 0.77
Cell surface sialylation and fucosylation are regulated by L1 via phospholipase Cgamma and cooperate to modulate neurite outgrowth, cell survival and migration. PLoS One (2008) 0.77
Anti-glioma response of autologous T cells stimulated by autologous dendritic cells electrofused with CD133+ or CD133- glioma cells. J Neuroimmunol (2011) 0.76
Recombinant DNA vaccine against inhibition of neurite outgrowth promotes functional recovery associated with endogeous NGF expression in spinal cord hemisected adult rats. Neurochem Res (2009) 0.76
The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation. Br J Pharmacol (2015) 0.76
Notch as a molecular switch in neural stem cells. IUBMB Life (2010) 0.76
Letter from the guest editors: Introduction to molecular and cellular events controlling neuronal and brain function and dysfunction. Cell Adh Migr (2009) 0.75
Abnormal myelination in the spinal cord of PTPα-knockout mice. Cell Adh Migr (2013) 0.75
Application of echocardiography in resynchronization treatment of heart failure patients. Chin Med J (Engl) (2012) 0.75
Bosentan and antiretroviral therapy in an HIV/HBV/HCV coinfected Chinese patient with HIV-related pulmonary arterial hypertension. Chin Med J (Engl) (2013) 0.75
Retracted Therapeutic DNA vaccination as a repair strategy following spinal cord injury. Cell Mol Neurobiol (2009) 0.75